Literature DB >> 8666197

Analysis of the catalytic domain of the lysin of the lactococcal bacteriophage Tuc2009 by chimeric gene assembling.

M M Sheehan1, J L García, R López, P García.   

Abstract

An active chimeric cell wall lytic enzyme (Tsl) has been constructed by fusing the region coding for the N-terminal half of the lactococcal phage Tuc2009 lysin and the region coding for the C-terminal domain of the major pneumococcal autolysin. The chimeric enzyme exhibited a glycosidase activity capable of hydrolysing choline-containing pneumococcal cell walls. This experimental approach demonstrated that the Tuc2009 lysin possesses a modular structure and further supports the hypothesis that many cell wall lytic enzymes have evolved by the fusion of preexisting catalytic and peptidoglycan-binding domains.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8666197     DOI: 10.1111/j.1574-6968.1996.tb08309.x

Source DB:  PubMed          Journal:  FEMS Microbiol Lett        ISSN: 0378-1097            Impact factor:   2.742


  11 in total

1.  LambdaSa1 and LambdaSa2 prophage lysins of Streptococcus agalactiae.

Authors:  David G Pritchard; Shengli Dong; Marion C Kirk; Robert T Cartee; John R Baker
Journal:  Appl Environ Microbiol       Date:  2007-09-28       Impact factor: 4.792

2.  Identification and characterization of a lysis module present in a large proportion of bacteriophages infecting Streptococcus thermophilus.

Authors:  M M Sheehan; E Stanley; G F Fitzgerald; D van Sinderen
Journal:  Appl Environ Microbiol       Date:  1999-02       Impact factor: 4.792

Review 3.  Recombinant bacteriophage lysins as antibacterials.

Authors:  Mark Fenton; Paul Ross; Olivia McAuliffe; Jim O'Mahony; Aidan Coffey
Journal:  Bioeng Bugs       Date:  2010 Jan-Feb

4.  Chimeric Ply187 endolysin kills Staphylococcus aureus more effectively than the parental enzyme.

Authors:  Jinzhe Mao; Mathias Schmelcher; William J Harty; Juli Foster-Frey; David M Donovan
Journal:  FEMS Microbiol Lett       Date:  2013-03-15       Impact factor: 2.742

5.  Genomic sequence and characterization of the virulent bacteriophage phiCTP1 from Clostridium tyrobutyricum and heterologous expression of its endolysin.

Authors:  Melinda J Mayer; John Payne; Michael J Gasson; Arjan Narbad
Journal:  Appl Environ Microbiol       Date:  2010-06-25       Impact factor: 4.792

Review 6.  Bacteriophage endolysins as novel antimicrobials.

Authors:  Mathias Schmelcher; David M Donovan; Martin J Loessner
Journal:  Future Microbiol       Date:  2012-10       Impact factor: 3.165

7.  Synergism between a novel chimeric lysin and oxacillin protects against infection by methicillin-resistant Staphylococcus aureus.

Authors:  Anu Daniel; Chad Euler; Mattias Collin; Peter Chahales; Kenneth J Gorelick; Vincent A Fischetti
Journal:  Antimicrob Agents Chemother       Date:  2010-01-19       Impact factor: 5.191

8.  Bacteriophage Tuc2009 encodes a tail-associated cell wall-degrading activity.

Authors:  John G Kenny; Stephen McGrath; Gerald F Fitzgerald; Douwe van Sinderen
Journal:  J Bacteriol       Date:  2004-06       Impact factor: 3.490

9.  Genomic sequence of bacteriophage ATCC 8074-B1 and activity of its endolysin and engineered variants against Clostridium sporogenes.

Authors:  Melinda J Mayer; Michael J Gasson; Arjan Narbad
Journal:  Appl Environ Microbiol       Date:  2012-03-16       Impact factor: 4.792

10.  Domain shuffling and module engineering of Listeria phage endolysins for enhanced lytic activity and binding affinity.

Authors:  Mathias Schmelcher; Vincent S Tchang; Martin J Loessner
Journal:  Microb Biotechnol       Date:  2011-04-27       Impact factor: 5.813

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.